Tuberculosis in HIV-negative and HIV-infected patients in a low-incidence country: Clinical characteristics and treatment outcomes

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Fenner, Lukas ^a   Gagneux, Sebastien ^b,c   Janssens, Jean Paul ^d   Fehr, Jan ^e   Cavassini, Matthias ^f   Hoffmann, Matthias ^g   Bernasconi, Enos ^h   Schrenzel, Jacques ^d   Bodmer, Thomas ^a   Böttger, Erik C ⁱ   Helbling, Peter ^j   Egger, Matthias ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^c UNIVERSITY OF BASEL   (Switzerland)

^d GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^e UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^f LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^g CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^h REGIONAL HOSPITAL OF LUGANO   (Switzerland)

ⁱ UNIVERSITY OF ZURICH   (Switzerland)

^j FEDERAL OFFICE OF PUBLIC HEALTH   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN;

ADULT; ARTICLE; BACTERIUM CULTURE; CD4 LYMPHOCYTE COUNT; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIGRANT WORKER; MYCOBACTERIUM TUBERCULOSIS; PROSPECTIVE STUDY; SWITZERLAND; TREATMENT OUTCOME; TUBERCULOSIS; CD4+ T LYMPHOCYTE; COMORBIDITY; CYTOLOGY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MIDDLE AGED; MIGRATION; RISK; VIROLOGY;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; COMORBIDITY; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK; SWITZERLAND; TRANSIENTS AND MIGRANTS; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 84859150623     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034186     Document Type: Article

References (26)

1. Corbett EL, Marston B, Churchyard GJ, De Cock KM, (2006) Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment. Lancet 367: 926-937.
2. Selwyn PA, Alcabes P, Hartel D, Buono D, Schoenbaum EE, et al. (1992) Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection. N Engl J Med 327: 1697-1703.
3. Havlir DV, Barnes PF, (1999) Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 340: 367-373.
4. Braitstein P, Brinkhof MW, Dabis F, Schechter M, Boulle A, et al. (2006) Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 367: 817-824.
5. Sudre P, Hirschel B, Toscani L, Ledergerber B, Rieder HL, et al. (1996) Risk factors for tuberculosis among HIV-infected patients in Switzerland. Eur Respir J 9: 279-283.
6. Federal Office of Public Health (2011) "Tuberkulose in der Schweiz 2005-2009". Bull BAG.
7. Federal Office of Public Health (2011) Tuberkulose in der Schweiz 2005-2009. [Erratum appears in Bull Bundesamt für Gesundheit (Switzerland) 2011;(no 13):277]. Bull BAG no 10 pp. 205-213.
8. Rieder HL, Cauthen GM, Bloch AB, Cole CH, Holtzman D, et al. (1989) Tuberculosis and acquired immunodeficiency syndrome- Florida. Arch Intern Med 149: 1268-1273.
9. Elzi L, Schlegel M, Weber R, Hirschel B, Cavassini M, et al. (2007) Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission. Clin Infect Dis 44: 94-102.
10. Fenner L, Forster M, Egger M, for the ART-LINC collaboration of IeDEA (2011) Tuberculosis in HIV programmes in lower-income countries: practices and risk factors. Int J Tuberc Lung Dis 15: 620-627.
11. Wood R, Maartens G, Lombard CJ, (2000) Risk factors for developing tuberculosis in HIV-1-infected adults from communities with a low or very high incidence of tuberculosis. J Acquir Immune Defic Syndr 23: 75-80.
12. Gebhardt M, Rickenbach M, Egger M, (1998) Impact of antiretroviral combination therapies on AIDS surveillance reports in Switzerland. Swiss HIV Cohort Study. AIDS 12: 1195-1201.
13. Gras L, van Sighem A, Bezemer D, Smit C, Wit F, et al. (2011) Lower mortality and earlier start of combination antiretroviral therapy in patients tested repeatedly for HIV than in those with a positive first test. AIDS 25: 813-818.
14. Schoeni-Affolter F, Ledergerber B, Rickenbach M, Rudin C, Gunthard HF, et al. (2010) Cohort profile: the Swiss HIV Cohort study. Int J Epidemiol 39: 1179-1189.
15. Thiebaut R, Morlat P, Jacqmin-Gadda H, Neau D, Mercie P, et al. (2000) Clinical progression of HIV-1 infection according to the viral response during the first year of antiretroviral treatment. Groupe d'Epidemiologie du SIDA en Aquitaine (GECSA). AIDS 14: 971-978.
16. Fenner L, Gagneux S, Helbling P, Battegay M, Rieder HL, et al. (2011) Mycobacterium tuberculosis transmission in a low-incidence country: Role of immigration and HIV infection. J Clin Microbiol in press.
17. Helbling P, Medinger C, Altpeter E, Raeber PA, Beeli D, et al. (2002) Outcome of treatment of pulmonary tuberculosis in Switzerland in 1996. Swiss Med Wkly 132: 517-522.
18. Rieder HL, Watson JM, Raviglione MC, Forssbohm M, Migliori GB, et al. (1996) Surveillance of tuberculosis in Europe. Working Group of the World Health Organization (WHO) and the European Region of the International Union Against Tuberculosis and Lung Disease (IUATLD) for uniform reporting on tuberculosis cases. Eur Respir J 9: 1097-1104.
19. Veen J, Raviglione M, Rieder HL, Migliori GB, Graf P, et al. (1998) Standardized tuberculosis treatment outcome monitoring in Europe. Recommendations of a Working Group of the World Health Organization (WHO) and the European Region of the International Union Against Tuberculosis and Lung Disease (IUATLD) for uniform reporting by cohort analysis of treatment outcome in tuberculosis patients. Eur Respir J 12: 505-510.
20. Harries AD, (1998) The association between HIV and tuberculosis in the developing world. In: Davies PDO, editors. Clinical tuberculosis London Chapman & Hall Medical pp. 315-345.
21. Kherad O, Herrmann FR, Zellweger JP, Rochat T, Janssens JP, (2009) Clinical presentation, demographics and outcome of tuberculosis (TB) in a low incidence area: a 4-year study in Geneva, Switzerland. BMC Infect Dis 9: 217.
22. Faustini A, Hall AJ, Perucci CA, (2005) Tuberculosis treatment outcomes in Europe: a systematic review. Eur Respir J 26: 503-510.
23. Battegay M, Wirz M, Steuerwald MH, Egger M, (1998) Early participation in an HIV cohort study slows disease progression and improves survival. The Swiss HIV Cohort Study. J Intern Med 244: 479-487.
24. Mugavero MJ, Lin HY, Willig JH, Westfall AO, Ulett KB, et al. (2009) Missed visits and mortality among patients establishing initial outpatient HIV treatment. Clin Infect Dis 48: 248-256.
25. Thierfelder C, Weber R, Elzi L, Furrer H, Cavassini M, et al. (2011) Participation, characteristics and retention rates of HIV-positive immigrants in the Swiss HIV Cohort Study(*). HIV Med 10.1111/j.1468-1293.2011.00949.x [doi].
26. Wolff H, Janssens JP, Bodenmann P, Meynard A, Delhumeau C, et al. (2010) Undocumented migrants in Switzerland: geographical origin versus legal status as risk factor for tuberculosis. J Immigr Minor Health 12: 18-23.